Vascular surgeons at Massachusetts General Hospital (MGH) treated the first patient in New England in the Ventana U.S. Clinical Trial last week. MGH is one of 25 sites in the U.S. chosen to participate in this prospective,multicenter research study approved by the U.S. Food and Drug Administration to evaluate the safety and effectiveness of [...]